China Actinomycin D Factory

It really is a good way to further improve our goods and service. Our mission would be to acquire inventive items to buyers with a very good encounter for Actinomycin D,CAS NO 50-76-0,50-76-0,Actinomycin D API, We are keeping durable business relationships with more than 200 wholesalers in the USA, the UK, Germany and Canada. If you are interested in any of our products, please feel free to contact us.
Actinomycin D, We have been sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy you with our high-quality products and solutions and perfect service . We also warmly welcome customers to visit our company and purchase our products.

Hot Products

  • Bempedoic acid

    Bempedoic acid

    Product Name:Bempedoic acid
    Molecular Formula:C19H36O5
    Molecular Weight;344.49
    CAS Registry Number;738606-46-7
  • 3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine

    3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine

    3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine
    CAS NO:666816-98-4
    Molecular form:C10H9BrN4O2
    Mol. Weight: 297.11
    Usage:Linagliptin Intermediates​
  • Canagliflozin hemihydrate

    Canagliflozin hemihydrate

    Product Name:Canagliflozin hemihydrate
    Molecular Formula:2(C24H25FO5S).H2O
    Molecular Weight;462.53
    CAS Registry Number;928672-86-0
  • Palladium (II) Acetate

    Palladium (II) Acetate

    Product Name:Palladium (II) Acetate
    Molecular Formula:C2H4O2Pd
    Molecular Weight:166.47
    CAS Registry Number:3375-31-3
  • Doxorubicin hydrochloride

    Doxorubicin hydrochloride

    Product Name:Doxorubicin hydrochloride
    Molecular Formula:C27H30ClNO11
    Molecular Weight;579.98
    CAS Registry Number;25316-40-9
  • N-Methyl-2-pyrrolidone

    N-Methyl-2-pyrrolidone

    Product Name:N-Methyl-2-pyrrolidone
    Molecular Formula:C5H9NO
    Molecular Weight:99.13
    CAS Registry Number:872-50-4

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept